Abstract 1 Background 2 Genome-wide association studies (GWAS) provided many biological insights into coronary artery 3 disease (CAD), but these studies were mainly performed in Europeans. GWAS in diverse 4 populations have the potential to advance our understanding of CAD.
1
We downloaded the summary statistics of the CARDIoGRAMplusC4D 1000 Genomes 2 meta-analysis with UK Biobank data 4 from http://www.cardiogramplusc4d.org/data-downloads/, 3 which included 76,014 cases and 264,785 controls, mainly from European descendants, containing 4 9,026,567 SNPs. We used MR-MEGA software (ver. 0.1.2) for the transethnic meta-analysis. 14 
5
MR-MEGA provides a new approach, which demonstrated increased power over fixed-and 6 random-effects meta-analyses, for transethnic meta-analysis across a range of scenarios of 7 heterogeneity in allelic effects between ethnic groups. To perform the meta-analysis, the summary 8 statistics of 3 GWAS (the first, second Japanese GWAS and CARDIoGRAMplusC4D 1000 9 Genomes and UK Biobank) were provided to the MR-MEGA software. Because the number of PC 1 0 should be the cohort count -2, we set PC as 1 when running the software. To prioritize genes associated with GWAS signals, we evaluated eQTLs obtained from the 1 5
Genotype-Tissue Expression (GTEx) Portal (release v7) 15 and meQTLs from the Biobank-Based 1 6
Integrative Omics Study (BIOS). 16 We considered the overlap between a GWAS signal and a QTL 1 7 if the GWAS lead variant was in linkage disequilibrium (r 2 ≥ 0.8 in 1KG phase I European and East 1 8
Asian samples) with the lead variant of the eQTL or meQTL. Furthermore, we used the eQTL data 1 9 of five subsets of immune cells (CD4 + T cells, CD8 + T cells, B cells, natural killer cells, and 2 0 monocytes) from healthy Japanese individuals to assess gene expression in immune system-related 2 1 cells thoroughly. 17 In addition, we analyzed the GWAS results of 58 quantitative clinical traits in 2 2 the Japanese population to assess clinical parameters affected by GWAS signals. 18 The reported 2 3 genes and traits were filtered using a threshold false discovery rate (FDR) of < 0.05. 
0
We prepared independent SNPs with P-values < 1 × 10 -5 in the transethnic meta-analysis using 1 1 PLINK 1.90beta software (--clump-p1 1e-5 --clump-kb 500 -clump-r2 0.05) and obtained 230 1 2 suggestive significant variants for gene prioritization. DEPICT assigned genes to associated 1 3 regions if the genes resided within or were overlapping with the window in either direction with LD 1 4 r 2 > 0.5 to a given SNP. If there were no genes within the locus defined by r 2 > 0.5, the nearest 1 5 gene was selected. Using these prioritized genes, DEPICT identified enriched tissues and cell types.
6
We set a significant threshold of FDR <0.05 for the analysis. Default settings were used in all 1 7 software analysis unless otherwise noted. 1 8 1 9
Results

0
Susceptibility loci for CADs
1
We first conducted two Japanese GWAS comprised of 12,494 cases and 28,879 controls, 2 2 and 2,808 cases and 7,261 controls, respectively. Because elevated genomic inflation factors (λ GC ) 2 3 were observed (λ GC = 1.29 in the first GWAS and λ GC = 1.09 in the second GWAS) despite stringent 2 4 quality controls, GC corrections were applied (Supplemental Figure 2 ). Then, a meta-analysis of 2 5 these GWAS was performed using a fixed-effects model (Figure 1 ). The Japanese meta-analysis 2 6 12 included 5,932,413 variants. The λ GC in the Japanese meta-GWAS was sufficiently small (λ GC = 1 1.04) (Supplemental Figure 2 ). We identified a total of 18 loci that exceeded the GWS threshold of 2 P < 5 × 10 -8 in the Japanese meta-analysis (Supplemental Table 2 ), without evidence of 3 heterogeneity of effects (P het > 0.10). Of these loci, 16 had been previously reported, specifically 4 chromosome 1q41 (MIA3), 6p24 (PHACTR1), 6q23 (TCF21), 9p21 (CDKN2B-AS1), 9q33 (DAB2IP), 
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To further identify genetic loci associated with CAD, we performed a transethnic 1 3 meta-analysis by MR-MEGA using our two, GC-corrected Japanese GWAS and the European data 1 4 from the CARDIoGRAMplusC4D 1000 Genomes meta-analysis with UK Biobank data. In the 1 5 transethnic meta-analysis, 5,167,567 variants were included. We observed 3,581 GWS variants 1 6 clustering in 76 loci ( Supplemental Table 3 ), replicating 73 previously reported loci, but finding 3 1 7 novel loci (Table 1) . rs10488763, a lead variant identified in this transethnic meta-analysis and 1 8 rs1848599, a GWS lead variant in the Japanese meta-analysis, were within 1 MB. We conducted 1 9 conditional analyses using our two Japanese GWAS datasets and revealed that rs10488763 and 2 0 rs1848599 were located within the same loci since they did not reach GWS after conditioning 2 1 (Supplemental Figure 4 ). Collectively, 3 new loci, chromosome 1q21 (CTSS), 10q26 2 2 (WDR11-FGFR2), and 11q22 (RDX-FDX1), were discovered in our analyses.
3 4
Candidate genes and biological and clinical insights of newly identified loci 2 5 1 causal genes using the databases of eQTL in various cell types (GTEx) and peripheral blood cells 2 and for DNA methylation in whole blood (meQTL:BIOS). Epigenetic annotations of these loci 3 were explored using HaploReg. We also investigated the associations of these variants with clinical 4 measurements using the Japanese Encyclopedia of Genetic Associations by Riken (JENGER).
5
Additionally, we examined pleiotropy using the GWAS catalog database in order to find associations 6 with other traits ( hypertension. 21, 22 We found that rs6587520 was an eQTL for CTSS in the left ventricle and aorta, with decreased high-density lipoprotein cholesterol levels and elevated triglyceride levels in plasma 2 4 (Supplemental Table 5 ), which are traditional CAD risk factors. Apart from lipid-related traits, this 2 5 14 risk allele has been reported to be associated with increased body mass index, which is another 1 traditional CAD risk factor. 2 11q22: The lead variant, rs10488763, lies in an intergenic region between RDX and FDX1.
3
No histone marks were found in the variant, while rs1443120 (r 2 = 1 with the lead variant in 4 Europeans and East Asians) overlaps promoter histone marks in fat and blood cells. There are 5 associations of the risk allele T with increased expression of RDX in whole blood (GTEx) and 6 monocytes (JENGER). Furthermore, meQTL analyses revealed associations with RDX in whole 7 blood (BIOS). RDX encodes radixin, which is a cytoskeletal protein that plays an important role in 8 connecting actin to the plasma membrane. A previous report suggested that radixin controls 9 vascular smooth muscle cell migration, which is involved in pathophysiological processes such as 1 0 angiogenesis and atherosclerosis. 23 However, clinical measurements in the Japanese population and 1 1 pleiotropy analyses showed no associated traits or diseases. 1 2 1 3
Pathway analysis and CAD-related tissues and cell types 1 4
Using the result of the transethnic meta-analysis, we investigated biological pathways 1 5 associated with CAD using MAGENTA software. We found 25 significant biological pathways 1 6 (FDR < 0.05, Supplemental Table 6 ). Lipid-related pathways were most frequent (13/25), which 1 7 was followed by transport (4/25), signaling (3/25) pathways. These results suggest that the 1 8 development of CAD could involve a variety of biological processes, including lipid 1 9 metabolism/transport/homeostasis, inflammation, cell signaling/cycle/proliferation and regulation of 2 0 blood vessel.
1
Next, we performed tissue/cell-type enrichment analysis using DEPICT software (Table 3 ).
2
The most significant associations were observed in arteries (P = 3.05 × 10 -6 ). Moreover, we found 2 3 a significant enrichment in adrenal glands (P = 1.31 × 10 -5 ), which are endocrine glands and play an 2 4 important role in the regulation of metabolism, immune function and blood pressure. We also 2 5
found enrichment in fat tissues, confirming the association of lipid metabolism with CAD.
6
15 1
Susceptibility differences for CAD between Japanese and Europeans 2
We investigated the differences in genetic susceptibility to MI between Japanese and 3 Europeans. First, we compared all variants shared by both our Japanese meta-analysis and the 4 CARDIoGRAMplusC4D 1000 Genomes MI subphenotype analysis, where both cases were 5 comprised of MI patients (Supplemental Figure 5 ). While we found some common signals between 6 those two studies, population-specific signals were also observed. Next, using 76 lead variants 7 identified in our transethnic meta-analysis, we compared the odds ratios of those variants (Figure 3 ).
8
The odds ratios were very similar in most of the variants. We found a moderate correlation of odds 9 ratios between Japanese and Europeans (Spearman's ρ = 0.56, P = 1.21 × 10 -7 ). However, the odds 1 0 ratios for rs11124924, rs1250229, rs3130342, rs2107595, rs643434, rs1558803, rs7139170, and 1 1 rs62010554 were markedly different between the two cohorts as their 95% confidence intervals did 1 2 not reach the line of equality. This result suggests that the ABO locus, which harbors rs643434, is 1 3 preferentially linked to MI in Europeans, while the other 7 loci, APOB, FN1, ATF6B, HDAC9, 1 4 UBE3B, RPH3A, and ADAMTS7, are preferentially linked to MI in Japanese.
5
Next, we compared the risk allele frequency (RAF) of those variants in 1KG phase3 1 6 between East Asians, to which Japanese belong, and Europeans, in order to observe the distributions 1 7 in a population cohort (Figure4, Supplemental Table 7 ). We first confirmed strong correlations of 1 8
RAFs between our Japanese meta-analysis and 1KG phase3 East Asians (Spearman's ρ = 0.98, P = 1 9
1.50 × 10 -52 ), and the CARDIoGRAMplusC4D 1000 Genomes meta-analysis with UK Biobank data 2 0 and 1KG phase 3 Europeans (Spearman's ρ = 0.99, P = 2.71 × 10 -59 ), respectively. Then, we found 2 1 that there was no significant imbalance in the number between East Asian-frequent variants and 2 2
European-frequent variants (P for sign test = 0.91). When we assessed the 3 lead variants for newly 2 3 identified loci, we found just 1 variant was more frequent for East Asians (rs10488763: 37% in East 2 4
Asians vs. 11% in Europeans), while the others were more frequent for Europeans (rs6587520: 46% 2 5
in East Asians vs 48% in Europeans, rs2257129: 61% in East Asians vs 97% in Europeans). In 2 6 16 contrast to the RAFs, rs10488763 did not reach a suggestive significance level (P < 1 x 10 -5 ) in the 1 CARDIoGRAMplusC4D 1000 Genomes meta-analysis with UK Biobank, while the others reached.
2
Taken together, both more frequent risk allele frequency in East Asians and increased sample size 3 may help to detect these new signal.
4
Finally, we divided 230 suggestive significant variants used in the tissue/cell-type 5 enrichment analysis into two groups, the East Asian-frequent group and the European-frequent group, 6 according to the RAF in 1KG phase3 (Supplemental Table 8 ). We then removed variants with the 7 absolute value of [RAF in East Asian -RAF in European] <0.05 because variants with small RAF 8 difference do not characterize the population-specificity. As a result, the East Asian-frequent group 9 had 93 variants, while the European-frequent group had 92 variants; Using these variants, we again 1 0 performed tissues/cell type enrichment analysis and found different types of enrichment ( Figure 5 , 1 1 Supplemental Table 9 ). The East Asian-frequent group showed significant enrichment in adrenal 1 2 glands and adrenal cortex, while there was a significant enrichment in arteries and fat tissues in the 1 3
European-frequent group. Variations in RAF can contribute to differences in the prevalence of 1 4 diseases among populations. 24 Thus, these findings suggest that there are differences in CAD 1 5 susceptibility between Japanese and Europeans. We conducted the largest Japanese GWAS for CAD to date, which was comprised of 1 9 15,302 cases and 36,140 controls. Additionally, we performed a transethnic meta-analysis with the 2 0
CARDIoGRAMplusC4D 1000 Genomes meta-analysis with UK Biobank data, including 88,192 2 1 cases and 162,544 controls. We finally validated 73 previously reported loci and identified 3 new 2 2 loci for CAD at the GWS level. Using the lead variants in the identified loci, we compared odds 2 3 ratios for MI and RAFs to elucidate the genetic differences between Japanese and Europeans.
Akiyama et al. reported that the lead variant rs2257129 in the new loci WDR11-FGFR2 is 2 5 associated with body mass index, 25 which is a clinical measure of obesity. Because obesity is a 2 6 17 conventional risk factor for CAD, it seems natural to suppose that the locus linked to obesity is 1 associated with the development of CAD. Additionally, clinical QTL analyses using the JENGER 2 database suggested that rs2257129 is associated with triglyceride and high-density lipoprotein 3 cholesterol levels in the blood, which are also known as clinical laboratory values associated with 4 CAD. Actually, a recent GWAS for CAD reported that this variant reached a threshold for 5 suggestive significance (5e-7). 6 However, our analyses showed no significant eQTL or meQTL 6 genes for rs2257129, which could have explained a molecular mechanism between the genetic 7 variation and phenotype. Further research is necessary to improve our understanding of how 8 rs2257129 affects body mass index, triglycerides, high-density lipoprotein cholesterol, and the 9 development of CAD.
0
The findings from eQTL and meQTL analyses indicated that rs6587520, the lead variant in 1 1 the CTSS locus, modulates the expression of cathepsin genes (i.e., CTSS and CTSK) in immune cells.
2
Cathepsins are lysosome-restricted proteases, which have been reported to be related to many 
9
Pathway analysis showed that lipid metabolism pathway was the most relevant for CAD.
0
Furthermore, tissue/cell-type enrichment analysis confirmed the involvement of fat tissues such as 1 1 subcutaneous fat and abdominal fat in CAD. In addition, our analysis suggested the involvement of 1 2 adrenal glands in the disease biology. The adrenal glands play a multi-functional role in the 1 3 endocrine system and produce a variety of hormones such as catecholamines and corticosteroids.
4
Catecholamines regulate the heart rate and blood pressure, while corticosteroids influence stress 1 5 response, immune response, regulation of inflammation, and carbohydrate metabolism. These 1 6 findings suggest an endocrine system regulated by the adrenal glands plays an important role in the 1 7 development of CAD, as well as lipid metabolism.
8
The majority of previous GWAS for CAD were conducted in European populations, 3-5 and 1 9
we found a relatively small number of GWAS performed in non-European populations. 1, 2 A 2 0 previous study suggested that the directions of effect in CAD-related loci were generally concordant 2 1 between Europeans and non-Europeans, 30 and our study also demonstrated that the directions and 2 2 sizes of the effect of the lead variants detected in our transethnic meta-analysis were almost the same 2 3 between Japanese and Europeans. However, 7 out of the 76 variants had a greater effect and one 2 4 had a lesser effect in the Japanese population. Aside from the effect sizes, we found different 2 5 distributions in the RAFs of those variants between Japanese and Europeans. Especially, the RAFs 2 6 19 in 1 new locus, rs10488763, was higher in East Asians than in Europeans, which may have resulted 1 in exceeding a GWS threshold in our transethnic meta-GWAS encompassing more East Asians than 2 in previous studies. Since there are differences in genetic architecture across populations, it is 3 crucial to perform GWAS for CAD in other populations.
4
In the tissue/cell-type enrichment analysis for each population, we identified significant 5 enrichment of adrenal glands in East Asians, while we found an enrichment of arteries and fat tissues 6 for Europeans. This difference could explain different susceptibilities to CAD between East Asians 7 and Europeans from a biological perspective. With respect to fat tissues-which is significantly 8 associated with atherosclerosis-East Asians including Japanese have the lowest amount of 9 subcutaneous fat compared to other populations, suggesting that lipid spillover can easily occurr. 31 1 0
Consistent with this, it was reported that Japanese Americans had greater levels of atherosclerosis 1 1 compared to European Americans, 32 despite the lower rate of CAD in Japan. This report implies that 1 2 genetically, Japanese are not less prone to atherosclerosis. As such, these findings could explain a 1 3 part of the difference in the genetic basis of CAD between East Asians and Europeans.
Our study has some limitations. First, we adopted the CARDIoGRAMplusC4D 1000 1 5
Genomes meta-analysis with UK Biobank data for the CAD study in European populations. While 1 6 most of these samples (~91%) are of European descent, a small portion is of East Asian descent.
7
This could lead to underestimation of the differences in the effect size in CAD loci between Japanese 1 8 and Europeans. However, we were successful in identifying several differences despite the 1 9 conservative settings. Second, the sample size in our Japanese study was modest compared to that 2 0 of recent CAD GWAS, which resulted in a smaller number of new loci. Because population 2 1 2.16 × 10 -6 1.73 × 10 -4 7.96 × 10 -5 9.33 × 10 -10 9.33 × 10 -10 Chr., chromosome; A1, effect allele; A2, non-effect allele; freq., frequency; OR, odds ratio; CI, confidence interval; UKBB, UK Biobank.
All significant loci in the Japanese meta-analysis and transethnic meta-analysis are shown in Supplemental Table 2 and 3. MeSH, Medical Subjects Heading. FDR, false discovery rare.
Top 10 tissues/cell types are shown.
Figure 1. Overall design for GWAS
Two stage meta-analyses were conducted. In stage 1, Japanese meta-GWAS was performed using BioBank Japan and OACIS, which identified one new CAD loci. In stage 2, BioBank Japan, OACIS, and CARDIoGRAMplusC4D 1000 Genomes meta-analysis with UK Biobank were combined, which identified 3 novel loci. Since one locus was shared between stage 1 and stage 2, three new loci were finally identified. 
Figure 2. Manhattan plots in the Japanese meta-analysis and transethnic meta-analysis
Manhattan plot for A, Japanese meta-GWAS (15,302 CAD cases and 36,140 controls), B, Transethnic meta-analysis (91,316 CAD cases and 300,925 controls). The x axis denotes chromosomal location and y axis denotes -log 10 P value for each SNP. The horizontal red line shows a threshold of GWS (P = 5.0 × 10 -8 ). Red and blue dots represent novel and known GWS loci (lead variants ± 250 kb), respectively.
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Figure 3. Odds ratios of lead variants for MI between Japanese and Europeans
Scatter plot of odds ratios (ORs) between Japanese (x axis) and CardiogramPlusC4D (y axis) for MI using 76 lead variants in the transethnic meta-analysis. Variants whose 95% confidence interval did not reach the line of equality (y =
x) are shown in red. Error bars represent the 95% confidence interval for each variant.
Figure 4. Distribution of RAFs of 77 lead variants between East Asians and Europeans
Scatter plot of risk allele frequencies (RAFs) between East Asians (x axis) and Europeans (y axis) for MI using 76 lead variants in our transethnic meta-analysis and 1 lead variant (rs7623687) found only in the CARDIoGRAMplusC4D 1000 Genomes-based GWAS. Although rs7623687 showed a genome-wide significant association with MI in the CARDIoGRAMplusC4D 1000 Genomes-based GWAS, we did not use this variant because it was monomorphic in East
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Asians. RAFs were based on 1000 Genomes Project Phase 3. Novel loci are shown in red. Circles denote 76 lead variants of genome-wide significant loci in our transethnic meta-analysis, while a triangle denotes a monogenic locus in East Asians. EAS, East Asians; EUR, Europeans. 
